Skip to content

Comparison of ERAT and Conservative Therapy for Uncomplicated Acute Appendicitis

Comparison of ERAT and Conservative Therapy for Uncomplicated Acute Appendicitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048205
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncomplicated Acute Appendicitis

Interventions

Group A:ERAT combined with antibiotic therapy
Group B:Conservative treatment with antibiotics alone

Sponsors

First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years, gender is not limited. 2. Clinical manifestations of UCAA (acute uncomplicated appendicitis): (1) Clinical manifestations combined with acute appendicitis (symptoms + signs + laboratory test results, that is, Alvarado score >= 5); (2) CT or color Doppler ultrasound conforms to UCAA: 1) The appendix is visible in shape, with an inner diameter of 6-15mm; 2) and/or: fat streak sign around the appendix; calculi and gas shadows in the appendix; thickening of the intestinal wall around the appendix (cecum>4mm/ileum>2mm); 3) Exclude any one of the following: fluid around the appendix; ascites; gas shadow outside the appendix; causing suppurative portal phlebitis. 3. No mental illness.

Exclusion criteria

Exclusion criteria: 1. Refuse to sign the informed consent; 2. History of IBD; 3. Pregnant and lactating women; 4. Long-term hormone, anticoagulant therapy, severe bleeding tendency; 5. Severe cardiovascular and cerebrovascular diseases, severe abnormal liver and kidney functions, and mental disorders; 6. Life expectancy < 6 months / those who cannot complete the follow-up process for more than 6 months; 7. CT clearly indicates acute perforated appendicitis/periappendiceal abscess/peritonitis; 8. Those who have been included in other studies and have an influence on this study; 9. There are contraindications to CT.

Design outcomes

Primary

MeasureTime frame
Duration of post-treated pain;

Secondary

MeasureTime frame
Surgical expenses (including lost income from absenteeism);Duration of absence from work and sports;Pain medication requirements;Hospital stay;The overall complication rate;Recurrent appendicitis rate;Types and times of antibiotics used;Time for inflammation indicators to return to normal;Stent implantation;Discharge without symptom relief rate;

Countries

China

Contacts

Public ContactKong Lingjian

First Affiliated Hospital of Zhengzhou University

konggewww@sina.com+86 15713698818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026